Marco Costantini

711 total citations
20 papers, 495 citations indexed

About

Marco Costantini is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Marco Costantini has authored 20 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Microbiology and 5 papers in Infectious Diseases. Recurrent topics in Marco Costantini's work include Bacterial Infections and Vaccines (6 papers), Pneumonia and Respiratory Infections (5 papers) and Mosquito-borne diseases and control (4 papers). Marco Costantini is often cited by papers focused on Bacterial Infections and Vaccines (6 papers), Pneumonia and Respiratory Infections (5 papers) and Mosquito-borne diseases and control (4 papers). Marco Costantini collaborates with scholars based in Italy, Netherlands and Germany. Marco Costantini's co-authors include Piero Ruggenenti, Paolo Cravedi, Giuseppe Remuzzi, Annalisa Perna, Sanjeev Sharma, Vincenzo Gambara, Elena Perticucci, Peter M.A. Calverley, Vito Brusasco and Alberto Papi and has published in prestigious journals such as Journal of the American Society of Nephrology, Journal of Endodontics and Vaccine.

In The Last Decade

Marco Costantini

18 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Costantini Italy 10 128 114 80 66 65 20 495
Thierry Lobbedez France 10 58 0.5× 159 1.4× 22 0.3× 91 1.4× 55 0.8× 51 441
Precil Diego Miranda de Menezes Neves Brazil 12 70 0.5× 229 2.0× 39 0.5× 19 0.3× 43 0.7× 74 546
M. Papadimitriou Greece 15 115 0.9× 194 1.7× 17 0.2× 69 1.0× 62 1.0× 49 577
Vimarsh Raina India 11 38 0.3× 12 0.1× 78 1.0× 38 0.6× 57 0.9× 81 514
Seth J. Rotz United States 15 57 0.4× 35 0.3× 15 0.2× 25 0.4× 100 1.5× 62 664
M. Hanoy France 11 72 0.6× 141 1.2× 12 0.1× 67 1.0× 15 0.2× 25 450
Yaacov Goykhman Israel 12 143 1.1× 24 0.2× 14 0.2× 58 0.9× 30 0.5× 31 573
Jordi Ara Spain 11 134 1.0× 112 1.0× 36 0.5× 8 0.1× 13 0.2× 23 542
M. Pappalettera Italy 13 39 0.3× 56 0.5× 35 0.4× 39 0.6× 29 0.4× 29 595
Melina de Barros Pinheiro Brazil 18 50 0.4× 9 0.1× 30 0.4× 15 0.2× 139 2.1× 46 874

Countries citing papers authored by Marco Costantini

Since Specialization
Citations

This map shows the geographic impact of Marco Costantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Costantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Costantini more than expected).

Fields of papers citing papers by Marco Costantini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Costantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Costantini. The network helps show where Marco Costantini may publish in the future.

Co-authorship network of co-authors of Marco Costantini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Costantini. A scholar is included among the top collaborators of Marco Costantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Costantini. Marco Costantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Tiberi, Paola, et al.. (2022). Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis. Drug Safety. 46(1). 99–108. 2 indexed citations
4.
Giuliani, Marzia Monica, Alessia Biolchi, Pavitra Keshavan, et al.. (2020). Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children. Human Vaccines & Immunotherapeutics. 17(5). 1442–1449. 1 indexed citations
6.
Lee, Hoan Jong, Dae Sun Jo, Yun Kyung Kim, et al.. (2019). One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea. Clinical and Experimental Vaccine Research. 8(2). 94–94. 2 indexed citations
8.
Costantini, Marco, et al.. (2016). Judgment Aggregation under Issue Dependencies. Proceedings of the AAAI Conference on Artificial Intelligence. 30(1).
9.
Costantini, Marco, et al.. (2015). SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.. PubMed. 46(4). 743–52. 1 indexed citations
10.
Jelı́nek, Tomáš, Jakob P. Cramer, Sebastian Dieckmann, et al.. (2015). Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine. Travel Medicine and Infectious Disease. 13(3). 241–250. 11 indexed citations
11.
Jelı́nek, Tomáš, Gerd Burchard, Sebastian Dieckmann, et al.. (2015). Short-Term Immunogenicity and Safety of an Accelerated Pre-Exposure Prophylaxis Regimen with Japanese Encephalitis Vaccine in Combination with a Rabies Vaccine: a Phase Iii, Multicenter, Observer-Blind Study. Journal of Travel Medicine. 22(4). 225–231. 14 indexed citations
12.
Benedetto, Sergio, Tindaro Cicero, Alberto Ciolfi, et al.. (2015). Evaluating scientific research in Italy: The 2004–10 research evaluation exercise. Research Evaluation. 24(3). 242–255. 54 indexed citations
13.
Lalwani, Sanjay, et al.. (2013). A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants. Human Vaccines & Immunotherapeutics. 9(9). 1903–1909. 9 indexed citations
14.
Conte, G., Manuele Mancini, Loredana Cerroni, Marco Costantini, & L Cianconi. (2013). Fluid filtration and dye leakage testing of Resilon/Epiphany and guttapercha/Pulp Canal Sealer root canal fillings. Open Journal of Stomatology. 3(9). 14–21. 3 indexed citations
15.
Mancini, Manuele, Roberto Felici, G. Conte, Marco Costantini, & L Cianconi. (2011). Accuracy of Three Electronic Apex Locators in Anterior and Posterior Teeth: An Ex Vivo Study. Journal of Endodontics. 37(5). 684–687. 36 indexed citations
16.
Calverley, Peter M.A., Piotr Kuna, Eduard Monsó, et al.. (2010). Beclomethasone/formoterol in the management of COPD: A randomised controlled trial. Respiratory Medicine. 104(12). 1858–1868. 81 indexed citations
17.
Ruggenenti, Piero, Elena Perticucci, Paolo Cravedi, et al.. (2008). Role of Remission Clinics in the Longitudinal Treatment of CKD. Journal of the American Society of Nephrology. 19(6). 1213–1224. 154 indexed citations
18.
Remuzzi, Giuseppe, Paolo Cravedi, Marco Costantini, et al.. (2007). Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation. Journal of the American Society of Nephrology. 18(6). 1973–1985. 78 indexed citations
19.
Padalino, Barbara, et al.. (2006). Effects of a new supplement and of the work in standardbred trotters performing early training. 17(3). 11–16. 1 indexed citations
20.
Bianco, P., et al.. (1987). Expression of tartrate-resistant acid phosphatase in bone marrow macrophages.. PubMed. 31(4). 433–40. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026